EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 73 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 72 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 72 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 72 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 72 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | – | 72 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 72 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | – | 72 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 72 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 72 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 72 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 72 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 72 | -42.4% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 125 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 125 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 125 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | +100.0% | 125 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 125 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | -50.0% | 125 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | – | 125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 217,029 | $2,225,000 | 6.42% |
| Knoll Capital Management, LLC | 350,238 | $3,590,000 | 3.29% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $7,840,000 | 3.01% |
| Broadfin Capital, LLC | 1,367,377 | $14,016,000 | 2.59% |
| P.A.W. CAPITAL CORP | 200,000 | $2,050,000 | 2.56% |
| 683 Capital Management, LLC | 1,860,529 | $19,071,000 | 2.12% |
| EcoR1 Capital, LLC | 1,060,043 | $10,865,000 | 1.37% |
| MANGROVE PARTNERS IM, LLC | 847,284 | $8,685,000 | 1.05% |
| KNOTT DAVID M | 234,448 | $2,403,000 | 1.01% |
| Trellus Management Company, LLC | 85,000 | $871,000 | 0.87% |